DLA Piper represented Nexvet Biopharma in IPO


DLA Piper - advises on Nexvet Biopharma IPO Please link to the article below which was posted in Feb 2015 by dlapiper.com website. In further news on Nexvet Biopharma, the Irish biopharmaceutical company which focuses on the health of companion animals,  DLA Piper announced that it represented the company in it's US$40m IPO. You can read the full article by clicking on the button below. DLA Piper News - "DLA Piper advises on Nexvet Biopharma IPO"